Eli Lilly Acquires Adverum Biotechnologies to Advance Gene Therapy for Vision Restoration
Eli Lilly and Company has announced a definitive agreement to acquire Adverum Biotechnologies, Inc., a clinical-stage biotechnology firm specializing in…
Eylea and Lucentis
Read More